New CEOs at Axovant, Destiny and Organovo mark a busy week for the biotech jobs scene
Peer Review is the weekly biopharma jobs report from Endpoints News.
→ Musculoskeletal company Flexion Therapeutics $FLXN said co-founder Neil Bodick will transition to CSO from CMO. Yamo Deniz becomes CMO. Deniz was VP and global head of medical for rare diseases at the Genzyme unit of Sanofi.
→ Rare diseases play PTC Therapeutics $PTCT said CFO Shane Kovacs will leave the company in mid-May. PTC is seeking a replacement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.